NextCure Inc (NAS:NXTC)
$ 1.17 0 (0%) Market Cap: 32.77 Mil Enterprise Value: -37.15 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 40/100

NextCure Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 13, 2020 / 01:00PM GMT
Release Date Price: $33.39 (-5.14%)
Alec Warren Stranahan
BofA Merrill Lynch, Research Division - Associate

Hey, Hello, everyone. Welcome to day 3 of the 2020 Bank of America Health Care Conference. My name is Alec Stranahan, and I am an analyst on the biopharma team here at BofA. This session with NextCure will last approximately 30 minutes and will include some prepared remarks and slides by the company, followed by some brief Q&A. If you are accessing the event through the Veracast platform, please note that you will be advancing the slides on your own, and you will have the option to submit questions at any time throughout the session. Your questions will be kept anonymous.

And with that, it's my pleasure to introduce Dr. Timothy Mayer, Chief Operations Officer; and Steve Cobourn, Chief Financial Officer of NextCure. Tim and Steve, are you there?

Timothy Mayer
NextCure, Inc. - COO

Yes, we are. All right. Thank you.

Alec Warren Stranahan
BofA Merrill Lynch, Research Division - Associate

Perfect. Great. We'll -- Tim, I'll turn the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot